Grant: $499,997 - National Institutes of Health - Sep. 21, 2009
No votes have been cast for this award yet
Award Description: Recent studies suggest that metformin is the best oral medication for initial treatment of diabetes and that starting metformin immediately when diabetes is first detected, rather than waiting until blood sugars reach a somewhat higher target level, could delay progression of diabetes and prevent complications such as heart disease, stroke and kidney disease. This study compares very early treatment with metformin to more traditional approaches in a population of nearly 40,000 newly diagnosed diabetic patients from 4 large health care systems. If an advantage is shown for early use of metformin, the study's findings could dramatically change the way in which type 2 diabetes is treated in the U.S. and reduce the burden of complications from this very common condition.
Project Description: As defined in the Award Description.
Jobs Summary: NA (To date, no jobs created or retained.) (Total jobs reported: 0)
Project Status: Less Than 50% Completed
This award's data was last updated on Sep. 21, 2009. Help expand these official descriptions using the wiki below.